2 most recent filings and news items mentioning INMB. Updated every 60 seconds.
OtherJun 17, 2026Neutral
Inmune Bio Inc. has amended and restated its 2021 Stock Incentive Plan to provide equity awards to executives, employees, advisors and board members. The plan modification enables the company to continue incentivizing talent retention and aligning employee interests with long-ter
View filing at SEC.gov →
RegulatoryJun 2, 2026Positive
INmune Bio reported Phase 2 MINDFuL trial results showing XPro1595 demonstrated significant treatment effects on advanced white matter MRI biomarkers (p=0.0028), with stronger efficacy in inflammation-enriched patients. The findings support the company's precision-medicine approa
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.